Clincosm LogoSign in Get a demo

Schizophrenia

Showing NaN - NaN of 128
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Agitation,Psychomotor, Bipolar I Disorder, Bipolar II Disorder Trial in United States (BXCL501, Matching Placebo)

Recruiting
  • Agitation,Psychomotor
  • +5 more
  • Little Rock, Arkansas
  • +16 more
Jan 31, 2023

Schizophrenia Trial in Bentonville, Sherman Oaks, Chicago (CVL-231 15 mg, Required CVL-231 30 mg, Placebo)

Recruiting
  • Schizophrenia
  • CVL-231 15 mg
  • +2 more
  • Bentonville, Arkansas
  • +12 more
Jan 27, 2023

Schizophrenia Trial in United States (SEP-363856)

Recruiting
  • Schizophrenia
  • Culver City, California
  • +14 more
Jan 26, 2023

Schizophrenia Trial in Miami, Chicago, Buffalo (Valbenazine, Placebo)

Recruiting
  • Schizophrenia
  • Miami, Florida
  • +2 more
Jan 20, 2023

Schizophrenia Trial in United States (Xanomeline and Trospium Chloride Capsules)

Recruiting
  • Schizophrenia
  • Xanomeline and Trospium Chloride Capsules
  • Little Rock, Arkansas
  • +52 more
Jan 17, 2023

Schizophrenia Trial in Worldwide (MK-8189, Risperidone, Placebo to MK-8189)

Recruiting
  • Schizophrenia
  • Bentonville, Arkansas
  • +92 more
Jan 5, 2023

Schizophrenia Trial in Worldwide (SEP-363856 75mg, SEP-363856 100mg, Placebo)

Recruiting
  • Schizophrenia
  • SEP-363856 75mg
  • +2 more
  • Little Rock, Arkansas
  • +63 more
Dec 12, 2022

Schizophrenia Trial (CVL-231 30 mg)

Enrolling by invitation
  • Schizophrenia
  • CVL-231 30 mg
  • Bentonville, Arkansas
  • +16 more
Dec 7, 2022

Schizophrenia Trial in Worldwide (BI 425809, Placebo)

Completed
  • Schizophrenia
  • BI 425809
  • Placebo
  • Little Rock, Arkansas
  • +50 more
Nov 7, 2022

Schizophrenia Trial in Worldwide (Placebo, AVP-786)

Recruiting
  • Schizophrenia
  • Little Rock, Arkansas
  • +81 more
Aug 23, 2022

Schizophrenia Trial in United States (CT-155 smartphone app)

Enrolling by invitation
  • Schizophrenia
  • CT-155 smartphone app
  • Culver City, California
  • +9 more
Aug 18, 2022

Schizophrenia, Schizophrenia; Psychosis Trial in Ukraine, United States (Xanomeline and Trospium Chloride Capsules, Placebo)

Recruiting
  • Schizophrenia
  • Schizophrenia; Psychosis
  • Xanomeline and Trospium Chloride Capsules
  • Placebo
  • Bentonville, Arkansas
  • +28 more
Aug 12, 2022

Schizophrenia, Bipolar I Disorder, Autism Spectrum Disorder (ASD) Trial in Puerto Rico, United States (Cariprazine Flexible

Recruiting
  • Schizophrenia
  • +2 more
  • Cariprazine Flexible Dose
  • Dothan, Alabama
  • +32 more
Aug 8, 2022

Blood Pressure, Schizophrenia Trial in United States (CVL-231)

Active, not recruiting
  • Blood Pressure
  • Schizophrenia
  • Bentonville, Arkansas
  • +9 more
Jul 11, 2022

Role Functioning Changes NOS

Terminated
  • Schizophrenia
  • +2 more
  • Chicago, Illinois
    Northwestern University
Jun 8, 2022

Schizophrenia Trial in Worldwide (BI 409306, Placebo)

Terminated
Has Results
  • Schizophrenia
  • BI 409306
  • Placebo
  • Phoenix, Arizona
  • +58 more
Apr 19, 2022

Schizophrenia Trial in United States (ASP4345, , risperidone)

Completed
Has Results
  • Schizophrenia
  • Cerritos, California
  • +26 more
Apr 14, 2022

Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010 156 mg treatment group, deltoid, LY03010 156

Recruiting
  • Schizophrenia
  • +11 more
  • LY03010 156 mg treatment group, deltoid
  • +3 more
  • Little Rock, Arkansas
  • +8 more
Apr 11, 2022

Schizophrenia Trial in United States (Brilaroxazine, Placebo)

Recruiting
  • Schizophrenia
  • Phoenix, Arizona
  • +17 more
Apr 1, 2022

Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders Trial in United States (Coordinated Specialty Care (CSC))

Recruiting
  • Schizophrenia
  • +4 more
  • Coordinated Specialty Care (CSC)
  • Chicago, Illinois
  • +5 more
Apr 4, 2022

Schizophrenia, Schizophreniform Disorder, Bipolar I Disorder Trial in Worldwide (ALKS 3831)

Active, not recruiting
  • Schizophrenia
  • +2 more
  • ALKS 3831
  • Little Rock, Arkansas
  • +85 more
Feb 10, 2022

Schizophrenia Trial in Worldwide (TV-46000, Placebo)

Completed
  • Schizophrenia
  • Phoenix, Arizona
  • +89 more
Feb 5, 2022

Schizophrenia, Schizophreniform Disorders, Bipolar I Disorder Trial in Worldwide (ALKS 3831, Olanzapine)

Completed
  • Schizophrenia
  • +2 more
  • Little Rock, Arkansas
  • +56 more
Jan 5, 2022

Schizophrenia Trial in United States (CTP-692, Placebo)

Completed
  • Schizophrenia
  • Little Rock, Arkansas
  • +23 more
Dec 13, 2021

Schizophrenia Trial in Worldwide (PP6M, PP3M 350 mg eq., PP3M 525 mg eq.)

Completed
Has Results
  • Schizophrenia
  • Rogers, Arkansas
  • +137 more
Nov 11, 2021